Low vitamin D status: Definition, prevalence, consequences, and correction

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 2, 2010, Pages 287-301

  Binkley, Neil ^a   Ramamurthy, Rekha ^a   Krueger, Diane ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

25 Hydroxyvitamin D; Deficiency; Insufficiency; Supplementation; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D;

BONE; CALCIUM ABSORPTION; CANCER PREVENTION; CANCER RISK; CLINICAL ASSESSMENT; DIABETES MELLITUS; DRUG MEGADOSE; ETHNICITY; FALLING; FRACTURE; HUMAN; IMMUNOMODULATION; LOW DRUG DOSE; MUSCLE FUNCTION; OSTEOPOROSIS; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SUN EXPOSURE; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

BONE AND BONES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MUSCLES; NEOPLASMS; NUTRITIONAL REQUIREMENTS; OSTEOMALACIA; PREVALENCE; RICKETS; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77953920571     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.02.008     Document Type: Review

References (122)

1. Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995, 61:638S-645S.
2. Holick M.F. The photobiology of vitamin D and its consequences for humans. Ann N Y Acad Sci 1985, 453:1-13.
3. Looker A.C., Dawson-Hughes B., Calvo M.S., et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002, 30:771-777.
4. Rucker D., Allan J.A., Fick G.H., et al. Vitamin D insufficiency in a population of healthy western Canadians. Can Med Assoc J 2002, 166:1517-1524.
5. Nesby-O'Dell S., Scanlon K.S., Cogswell M.E., et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002, 76:187-192.
6. Calvo M.S., Whiting S.J. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003, 61:107-113.
7. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
8. Binkley N. Does low vitamin D status contribute to " age-related" morbidity?. J Bone Miner Res 2007, 22:V55-V58.
9. DeLuca H.F. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 1988, 2:224-236.
10. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board, Institute of Medicine Dietary reference intakes for calcium phosphorus, magnesium, vitamin D and fluoride 1997, National Academy Press, Washington, DC.
11. Lips P., Chapuy M.C., Dawson-Hughes B., et al. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999, 9:394-397.
12. Binkley N., Krueger D., Cowgill C., et al. Assay variation confounds hypovitaminosis D diagnosis: a call for standardization. J Clin Endocrinol Metab 2003, 89:3152-3157.
13. Binkley N. Vitamin D: clinical measurement and use. J Musculoskelet Neuronal Interact 2006, 6:338-340.
14. Binkley N., Krueger D., Engelke J.A., et al. What is your patient's vitamin D status? Clinical consideration of variability in a 25(OH)D measurement. J Bone Miner Res 2008, 23(Suppl 1):S351.
15. Heaney R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80(Suppl):1706S-1709S.
16. Dawson-Hughes B., Heaney R.P., Holick M.F., et al. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.
17. McCollum E.V., Simmonds N., Becker J.E., et al. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922, 53:293-312.
18. Steenbock H. The induction of growth promoting and calcifying properties in a ration by exposure to light. Science 1924, 60:224-225.
19. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80(Suppl):1689S-1696S.
20. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22:477-501.
21. Holick M.F., Siris E.S., Binkley N., et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90:3215-3224.
22. Heaney R.P., Dowell M.S., Hale C.A., et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003, 22:142-146.
23. Need A.G., Nordin B.E.C. Misconceptions-vitamin D insufficiency causes malabsorption of calcium. Bone 2008, 42:1021-1024.
24. Need A.G., O'Loughlin P.D., Morris H.A., et al. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008, 23:1859-1863.
25. 3 under various input conditions. Am J Clin Nutr 2008, 87:1738-1742.
26. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
27. 3 photosynthesis in man: skin pigment is not an essential regulator. Science 1981, 211:590-593.
28. 3 availability in the shade?. Physiol Biochem Zool 2005, 78:193-200.
29. Awumey E.M.K., Mitra D.A., Hollis B.W., et al. Vitamin D metabolism is altered in Asian Indians in the Southern United States: a clinical research center study. J Clin Endocrinol Metab 1998, 83:169-173.
30. Binkley N., Novotny R., Krueger D., et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 2007, 92:2130-2135.
31. Barger-Lux M.J., Heaney R.P. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 2002, 87:4952-4956.
32. Tangpricha V., Turner A., Spina C., et al. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr 2004, 80:1645-1649.
33. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005, 135:317-322.
34. Hollis B.W. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes 2008, 15:489-494.
35. Kuchuk N.O., Pluijm S.M.F., van Schoor N.M., et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older adults. J Clin Endocrinol Metab 2009, 94:1244-1250.
36. Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169:626-632.
37. Lips P., Hosking D., Lippuner K., et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006, 260:245-254.
38. Orwoll E., Nielson C.M., Marshall L.M., et al. Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009, 94:1214-1222.
39. Hagenau T., Vest R., Gissel T.N., et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 2009, 20:133-140.
40. Looker A.C., Pfeiffer C.M., Lacher D.A., et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88:1519-1527.
41. Cauley J.A., La Croix A., Wu L., et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008, 149:242-250.
42. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293:2257-2264.
43. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch Intern Med 2009, 169:551-561.
44. Pfeifer M., Begerow B., Minne H.W. Vitamin D and muscle function. Osteoporos Int 2002, 13:187-194.
45. Janssen H.C.J.P., Samson M.M., Verhaar H.J.J. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002, 75:611-615.
46. Mingrone D., Greco A.V., Castagneto M., et al. A woman who left her wheelchair. Lancet 1999, 353:806.
47. Skaria J., Katiyar B.C., Srivastava T.P., et al. Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 1975, 51:37-58.
48. Glerup H., Mikkelsen K., Poulsen L., et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 2000, 66:419-424.
49. Flicker L., Mead K., MacInnis R.J., et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003, 51:1533-1538.
50. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999-2006.
51. Dawson-Hughes B., Harris S.S., Krall E.A., et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670-676.
52. Broe K.E., Chen T.C., Weinberg J., et al. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007, 55:234-239.
53. Wicherts I.S., van Schoor N.M., Boeke A.J.P., et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007, 92:2058-2065.
54. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009, 94:26-34.
55. Garland C.F., Garland F.C., Gorham E.D., et al. The role of vitamin D in cancer prevention. Am J Public Health 2006, 96:252-261.
56. Gorham E.D., Garland C.F., Garland F.C., et al. Optimal vitamin D status for colorectal cancer prevention A quantitative meta analysis. Am J Prev Med 2007, 32:210-216.
57. Giovannucci E., Liu Y., Rimm E.B., et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98:451-459.
58. Feskanich D., Ma J., Fuchs C.S., et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004, 13:1502-1508.
59. Garland C.F., Gorham E.D., Mohr S.B., et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem 2007, 103:708-711.
60. Wactawski-Wende J., Kotchen J.M., Anderson G.L., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006, 354:684-696.
61. Lappe J.M., Travers-Gustafson D., Davies K.M., et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.
62. Martineau A.R., Honecker F.U., Wilkinson R.J., et al. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007, 103:793-798.
63. Russell B. The history of lupus vulgaris: its recognition, nature, treatment and prevention. Proc R Soc Med 1954, 48:127-132.
64. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:170-173.
65. 3: Basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
66. 3 in the immune system. Arch Biochem Biophys 2002, 402:249-254.
67. Mahon B.D., Wittke A., Weaver V., et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003, 402:922-933.
68. 3. Arch Biochem Biophys 2000, 377:135-138.
69. Peterlik M., Cross H.S. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005, 35:290-304.
70. Froicu M., Weaver V., Wynn T.A., et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003, 17:2386-2392.
71. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 1996, 93:7861-7864.
72. 3 has a direct effect on naive CD4+ T cells to enhance the development of TH2 cells. J Immunol 2001, 167:4974-4980.
73. 3 on cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 1999, 84:3739-3744.
74. 3: Specific inhibition at the level of messenger RNA. J Clin Invest 1987, 79:1659-1664.
75. 3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 1985, 34:315-320.
76. Norman A.W., Frankel J.B., Heldt A.M., et al. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980, 209:823-825.
77. Rabinovitch A., Suarez-Pinzon W.L., Sooy K., et al. Expression of calbindin-D28K in a pancreatic islet b-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 2001, 142:3649-3655.
78. Mathieu C., Gysemans C., Guilietti A., et al. Vitamin D and diabetes. Diabetologia 2005, 48:1247-1257.
79. Zipitis C.S., Akobeng A.K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008, 93:512-517.
80. Pittas A.G., Lau J., Hu F.B., et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
81. Grimes D.S., Hindle E., Dyer T. Sunlight, cholesterol and coronary heart disease. QJM 1996, 89:579-589.
82. Voors A.W., Johnson W.D. Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States. J Chronic Dis 1979, 32:157-162.
83. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997, 30:150-156.
84. 3 levels: A community based study. Int J Epidemiol 1990, 19:559-563.
85. Poole K.E., Loveridge N., Barker P.J., et al. Reduced vitamin D in acute stroke. Stroke 2006, 37:243-245.
86. 3: studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989, 83:1903-1915.
87. 3-1 alpha hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111:1666-1671.
88. 3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 1987, 41:112-114.
89. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373.
90. Holick M.F. Too little vitamin D in premenopausal women: why should we care?. Am J Clin Nutr 2002, 76:3-4.
91. Giovannucci E. Can vitamin D reduce total mortality?. Arch Intern Med 2007, 167:1709-1710.
92. Anonymous Vitamin D deficiency: information for cancer patients 2008, The Bone and Cancer Foundation, New York.
93. Anonymous Clinician's guide to prevention and treatment of osteoporosis 2008, National Osteoporosis Foundation, Washington, DC.
94. 3 intake for the elderly. J Nutr 2006, 136:1123-1125.
95. 3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
96. 3 supplementation on serum 25OHD. J Bone Miner Res 2008, 23(Suppl 1):S350.
97. 3. J Clin Invest 1985, 76:1536-1538.
98. Weaver C.M., Fleet J.C. Vitamin D requirements: current and future. Am J Clin Nutr 2004, 80:1735S-1739S.
99. Matsuoka L.Y., Wortsman J., Haddad J.G., et al. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 1991, 127:536-538.
100. Anonymous National coalition for sun safety Available at:, Accessed February 10, 2010. http://www.aad.org/public/sunsafetydb.htm.
101. Task Force on Community Preventive Services Recommendations to prevent skin cancer by reducing exposure to ultraviolet radiation. Am J Prev Med 2004, 27:467-470.
102. Kirsner R.S., Parker D.F., Brathwaite N., et al. Sun protection policies in Miami-Dade county public schools: opportunities for skin cancer prevention. Pediatr Dermatol 2005, 22:513-519.
103. Anonymous Saving your skin from sun damage. Am Fam Physician 2006, 74:815-816.
104. Randle H.W. Suntanning: differences in perceptions throughout history. Mayo Clin Proc 1997, 72:461-466.
105. Skin cancer primary prevention and education initiative 2006 Sun safety at school: What you can do. Center for Disease Control; Guidelines for School. Available at: Accessed February 10, 2010. http://www.cdc.gov/cancer/skin/pdf/sunsafety_v0908.pdf.
106. US Environmental Protection Agency SunWise Program Available at:, Accessed February 10, 2010. http://www.epa.gov/sunwise.
107. Matsuoka L.Y., Wortsman J., Hanafin N., et al. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. Arch Dermatol 1988, 124:1802-1804.
108. Pepper K.J., Judd S.E., Nanes M.S., et al. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract 2009, 15:95-103.
109. Przybelski R., Agrawal S., Krueger D., et al. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 2008, 19:1621-1628.
110. Malabanan A., Veronikis I.E., Holick M.F. Redefining vitamin D insufficiency. Lancet 1998, 351:805-806.
111. Geller J.L., Adams J.S. Vitamin D therapy. Current Osteoporos Rep 2008, 6:5-11.
112. Ramamurthy R., Przybelski R., Gemar D., et al. Long-term high-dose vitamin D supplementation in the elderly is both safe and efficacious. J Clin Densitom 2009, 12:375-376.
113. 3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93:677-681.
114. Heaney R.P., Davies K.M., Chen T.C., et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
115. 3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomized Evaluation of Calcium or vitamin D, RECORD): a randomized-placebo-controlled trial. Lancet 2005, 365:1621-1628.
116. Wactawski-Wende J., Jackson R.D., LaCroix A.Z., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669-683.
117. Chesnut C.H.I. Treating osteoporosis with bisphosphonates and addressing adherence. Drugs 2006, 66:1351-1359.
118. Briefel R.R., Johnson C.L. Secular trends in dietary intake in the United States. Annu Rev Nutr 2004, 24:401-431.
119. Vieth R. Vitamin D toxicity, policy and science. J Bone Miner Res 2007, 22(Suppl 2):V64-V68.
120. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 1999, 69:842-856.
121. 2. Am J Clin Nutr 1998, 68:854-858.
122. Houghton L.A., Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006, 84:694-697.